16
Participants
Start Date
September 30, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
February 28, 2010
Methylphenidate Transdermal System
10mg for one week, with weekly stepwise increases to 15mg, 20mg, and 30mg for additional 7 weeks, if symptom reports remained elevated. Titration decreased one stepwise dosage
OU Child Study Center, Oklahoma City
Mark L. Wolraich, M.D.
UNKNOWN
University of Oklahoma
OTHER